Buscar resultados de ensayos clínicos
Non-Hodgkin Lymphoma, Childhood - 16 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Improve the Survival Rate of Chinese Children and Adolescents With Non-Hodgkin's Lymphoma Condición: Childhood Non-Hodgkin's Lymphoma Fecha: 2012-12-21 Intervenciones: Other: Modified BFM-90 protocol Using Modified BFM-90 protocol to treat Chinese children and Adolescents |
Completed |
Nombre del estudio: Statin Therapy in Young Adult Survivors of Childhood Cancer Condición:
|
Withdrawn |
Nombre del estudio: Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma Condición: Non-Hodgkin Lymphoma Fecha: 2014-05-07 Intervenciones: Drug: 6-thioguanine All eligible patients will be suppleme |
Terminated |
Nombre del estudio: Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma Condición: Lymphoma Fecha: 2006-01-10 Intervenciones:
|
Withdrawn |
Nombre del estudio: Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors Condición:
|
Recruiting |
Nombre del estudio: Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant Condición:
|
Active, not recruiting |
Nombre del estudio: Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma Condición:
|
Recruiting |
Nombre del estudio: Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT Condición:
|
Recruiting |
Nombre del estudio: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia Condición:
|